Übersetzung für "Practitioner pharmacology " (Englisch → Französisch) :

dispensing chemist | pharmacy practitioner | pharmacist | practitioner of pharmacology

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

complementary practitioner [ complementary medicine practitioner | alternative practitioner | complementary therapist | alternative therapist | practitioner of complementary medicine | practitioner of alternative medicine | alternative healer | alternative therapy practitioner | fringe therapist | fri ]

lead a clinical pharmacological study | lead clinical study on drug action | lead a clinical pharmacology study | lead clinical pharmacology studies

science of pharmacology | study of pharmacology | pharmacology | study of drug action

residue levels for pharmacologically active substances | residues of substances having a pharmacological action

pharmacologic action | pharmacological action

pharmacologic action | pharmacological action

Suggested fee guide for general practitioners [ ODA Suggested fee guide for general practitioners | Suggested fee guide for dental services provided by general practitioners ]

herbology practitioner [ remedial herbologist | herb practitioner | herbal practitioner | herbal specialist | herbalist | herbologist | remedial herbalist | herborist ]

For the purposes of points (a) and (b), Member States shall cooperate, under the coordination of the Executive Director of the Agency, in order to ensure that the final composition of the Paediatric Committee, including members and alternates, covers the scientific areas relevant to paediatric medicinal products, and including at least: pharmaceutical development, paediatric medicine, general practitioners, paediatric pharmacy, paediatric pharmacology, paediatric research, pharmacovigilance, ethics and public health.

However, from a practitioner's perspective, the practitioner being a physician, pharmacist or nurse practitioner, to read the literature in terms of what is happening with a particular product for off-label use, to speak to that particular product to students, for example, or to talk about certain molecules, realizing that we have a product — a molecule or drug — and we have the pharmacology of that drug.

(b) shall be a pharmacist or a practitioner registered with a provincial professional licensing authority or possess a degree in an applicable science — such as pharmacy, medicine, dentistry, veterinary medicine, pharmacology, organic chemistry or chemical engineering — that is awarded by a Canadian university or, if awarded by a foreign university, that is recognized by a Canadian university or a Canadian professional association; and

For the purposes of points (a) and (b), Member States shall cooperate, under the coordination of the Executive Director of the Agency, in order to ensure that the final composition of the Paediatric Committee, including members and alternates, covers the scientific areas relevant to paediatric medicinal products, and including at least: pharmaceutical development, paediatric medicine, general practitioners, paediatric pharmacy, paediatric pharmacology, paediatric research, pharmacovigilance, ethics and public health.